期刊文献+

阻塞性睡眠呼吸暂停综合征与椎动脉狭窄、血浆ET-1相关性研究 被引量:1

Correlation of obstructive sleep apnea syndrome with vertebral artery stenosis and plasma endothelin-1
在线阅读 下载PDF
导出
摘要 目的:探讨阻塞性睡眠呼吸暂停综合征(OSAHS)与椎动脉狭窄、血浆内皮素-1(ET-1)之间的关系。方法:选择经多导睡眠监测仪检测,睡眠呼吸暂停低通气指数(AHI)≥5次/h的104例OSAHS患者与AHI<5次/h的47例正常对照组患者作为研究对象,彩超检测患者椎动脉病变,酶联免疫反应测定血浆ET-1水平。结果:OSAHS组患者椎动脉狭窄发生率、斑块形成率明显高于对照组,分别为(29.8%vs12.8%)、(26.9%vs 10.6%),差异有统计学意义(P<0.05)。AHI与椎动脉V1、V2段平均血管内径(Vd)呈负相关(r=-0.31,P<0.05),与血浆ET-1水平无显著相关(P>0.05)。夜间最低动脉血氧(LSa O2)与Vd呈正相关,(r=0.36),与ET-1呈负相关(r=-0.41),均P<0.05。结论:OSAHS患者椎动脉狭窄、粥样硬化斑块发生率增高;反复呼吸暂停、夜间缺氧引起血浆ET-1升高可导致椎动脉损伤。 Objective: To investigate the correlation of obstructive sleep apnea-hypopnea syndrome( OSAHS) with vertebral artery stenosis and plasma endothelin-1( ET-1). Methods: Determined by polysomnographic monitor,104 OSAHS patients whose apnea-hypopnea index( AHI) ≥ 5 times / h( OSAHS group) and 47 patients whose AHI5times / h( normal control group) were included as the subjects in the study.Color Doppler ultrasound was used to examine vertebral artery lesions. Plasma ET-1 level was measured by enzyme-linked immunosorbent assay( ELISA). Results: The incidence of vertebral artery stenosis and plaque formation in OSAHS group were significantly higher than those in the control group( 29.8% vs. 12.8%,26.9% vs.10.6%),with statistically significant differences( P 0. 05). AHI was negatively correlated with mean vessel diameter in V1 and V2 segments( r =-0. 31,P 0. 05). No significant correlation was found between AHI and plasma ET-1 level. The night-time lowest arterial oxygen saturation( LSa O2) was positively correlated with Vd and negatively correlated with ET-1( r = 0. 36,r =-0. 41,all P 0. 05). Conclusion: The occurrence of vertebral artery stenosis and atherosclerotic plaque increase in OSAHS patients. Increased plasma ET-1 induced by recurrent apnea and night-time hypoxemia may lead to vertebral artery lesions.
出处 《广州医科大学学报》 2015年第3期57-60,共4页 Academic Journal of Guangzhou Medical University
关键词 阻塞性睡眠呼吸暂停综合征 椎动脉病变 内皮素-1 obstructive sleep apnea-hypopnea syndrome vertebral artery lesions endothelin-1
  • 相关文献

参考文献5

二级参考文献36

  • 1Fern6ndez-Real JM, Puig J, Serrano M, et al. Iron and obesity status- associated insulin resistance influence circulating fibroblast-growth factor-23 Concentrations. PLoS One, 2013, 8: e58961.
  • 2Goetz R, Beenken A, Ibrahimi OA, et al. Molecular insights into the Klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol, 2007, 27 : 3417-3428.
  • 3Lim K, Lu TS, Molostvov G, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation, 2012, 125: 2243-2255.
  • 4Kocetak P, Olszanecka-Glinianowicz M, Chudek J. Fibroblast growth factor 23--structure, function and role in kidney diseases. Adv Clin Exp Med, 2012, 21: 391-401.
  • 5Shimada T, Fukumoto S. FGF23 as a novel therapeutic target. Adv Exp Med Biol, 2012, 728: 158-170.
  • 6Yasuda S, Wada S, Kono S, et al. Tumor-induced osteomalacia: benign tumor recurrence after two surgical resections at two different medical institutions. Endocr Pract, 2013, 19: 1-20.
  • 7Parker BD, Schurgers LJ, Brandenburg VM, et al. The associations of fihroblast growth [actor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: theHeart and Soul Study. Ann Intern Med, 2010, 152: 640-648.
  • 8Mathis DA, Stehel EJ Jr, Beshay JE, et al. Intracranial phosphaturic mesenchymal tumors: report of 2 cases. J Neurosurg, 2013, 118 : 903-907.
  • 9Liu P, Bai X, Wang H, et al. Hypophosphatemia-mediated hypotension in transgenic mice overexpressing human FGF-23. Am J Physiol Heart Circ Physiol, 2009, 297: H1514-1520.
  • 10Jean G, Bresson E, Lorriaux C, et al. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients. Nephron Clin Pract, 2012, 120: c132-138.

共引文献1865

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部